3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematuria
1
Interventions
Rituximab
2
venetoclax
1
tafasitamab
1
pembrolizumab
1
glofitamab
1
fludarabine
1
avelumab
1
Valproic Acid
1
Melphalan
1
Ifosfamide
1
Gemcitabine
1
Etoposide
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Lymphoma, B-Cell
×
Valproic Acid
×
Clear all
NCT02144623
2017-03-03
PREVAIL
Lund University Hospital
Phase EARLY_PHASE1
Completed
4 enrolled